Drug intelligence / Profile preview

Au DENPs-FA-DTA

Development stage
Preclinical
Lead developer
Shanghai Jiao Tong University
Modality
Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intratumoral, Intravenous
01

Overview

Au DENPs-FA-DTA is a multifunctional nanoparticle-based imaging agent composed of dendrimer-entrapped gold nanoparticles (Au DENPs) functionalized with folic acid (FA) and diatrizoic acid (DTA). The gold nanoparticles are synthesized using G5 dendrimers as templates, subsequently modified with FA to target folate receptor-overexpressing tumor cells (such as HeLa cervical cancer cells), and with DTA to impart iodinated contrast properties. The conjugate is designed for targeted X-ray computed tomography (CT) imaging of cancer cells, leveraging both the high X-ray attenuation of gold and targeted cell uptake via FA-receptor binding. The system demonstrates high biocompatibility, minimal cytotoxicity, and specific tumor-targeting capability in vitro and in vivo, allowing visualization of tumors in animal models when administered intravenously or intratumorally. It is not delivered as a conventional therapeutic, but rather as a diagnostic/imaging probe for cancer detection and research applications[1].

Other names
Au dendrimer-entrapped gold nanoparticle-folic acid-diatrizoic acidFA-modified DENPsFA-modified gold nanoparticlesfolic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles
02

Targets

1C metabolism (One-carbon metabolism)

Beyond the preview

Go deeper on Au DENPs-FA-DTA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Au DENPs-FA-DTA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call